Results 261 to 270 of about 108,275 (303)

TGFβ1 attenuates microglial IL1β release through inhibition of NLRP3 inflammasome priming. [PDF]

open access: yesFront Immunol
Kalischer C   +8 more
europepmc   +1 more source

Proteomic and Transcriptomic Signatures of Poor Asthma Symptom Control in the U‐BIOPRED Cohort

open access: yesAllergy, EarlyView.
No stable features were identified as associated with asthma symptom control in transcriptomics or sputum proteomics. Higher TWEAKR/TNFRSF12A and MBL/MBP‐C serum levels increased the odds of uncontrolled symptoms, while higher MK08/MAPK8 and CD5L serum levels decreased the odds, after adjustment for clinical variables.
Joana Antão   +294 more
wiley   +1 more source

Towards a cure for gout: A two‑stage treat‐to‐target strategy from inflammation control to structural remission

open access: yes
Rheumatology &Autoimmunity, EarlyView.
Jiani Liu   +10 more
wiley   +1 more source

NLRP3 inflammasome-mediated platelet hyperreactivity in sickle cell mice is targetable by BTK inhibition. [PDF]

open access: yesBiochem Biophys Res Commun
Vogel S   +9 more
europepmc   +1 more source

The effects of high-intensity interval training on NLRP3 inflammasome and monocyte chemokine receptors in individuals with obesity. [PDF]

open access: yesPLoS One
Silveira ALPA   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy